Predictive Oncology Inc. announced Predictive Oncology's Good Manufacturing Practices (GMP) lab, which opens the opportunity to help clients move from pre-clinical drug development to the investigational new drug (IND) qualification, including phase 1 clinical trials. The company has begun accepting orders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | -18.75% | -8.89% | -56.53% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.53% | 72.2L | |
-7.16% | 18TCr | |
-4.86% | 6.55TCr | |
-4.28% | 4.71TCr | |
+10.32% | 4.34TCr | |
+8.14% | 4.18TCr | |
+15.76% | 2.95TCr | |
+15.53% | 2.48TCr | |
-5.88% | 2.4TCr | |
-5.38% | 2.35TCr |
- Stock Market
- Equities
- POAI Stock
- News Predictive Oncology Inc.
- Predictive Oncology Inc. Strengthens Offerings with GMP Lab